导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -10.91% | 840/1050 |
| 近一周 | -1.95% | 386/1104 |
| 近一月 | -2.86% | 332/1102 |
| 近一季 | 2.87% | 161/1092 |
| 近半年 | -7.17% | 685/1070 |
| 近一年 | -20.06% | 900/1018 |
| 近两年 | -0.03% | 887/926 |
| 近三年 | -0.77% | 684/834 |
| 成立以来 | 32.58% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-9.80% 995/1070 |
-6.56% 834/1101 |
- - |
- - |
| 2025 | -9.87% 959/1065 |
1.32% 697/1014 |
-5.83% 976/1038 |
1.56% 981/1050 |
-6.99% 801/1065 |
| 2024 | 23.43% 64/1011 |
6.56% 69/960 |
-0.39% 332/983 |
14.05% 297/991 |
1.95% 238/1011 |
| 2023 | 2.48% 69/952 |
3.32% 419/880 |
0.34% 168/895 |
-1.81% 148/915 |
0.66% 104/952 |
| 2022 | -7.76% 59/867 |
-13.84% 212/773 |
15.23% 116/806 |
-9.38% 207/845 |
2.51% 297/867 |
| 2021 | -4.79% 413/740 |
7.80% 21/580 |
14.31% 249/659 |
-23.91% 655/704 |
1.55% 375/740 |
| 2020 | 24.09% 371/554 |
6.96% 57/419 |
15.78% 338/466 |
2.21% 399/517 |
-1.97% 503/554 |
| 2019 | - - |
- - |
- - |
4.24% 218/390 |
6.91% 279/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 宝盈品牌消费股票C VS. 东吴新产业精选股票A(580008) |